319 related articles for article (PubMed ID: 18172104)
1. Reactivation of uveitogenic T cells by retinal astrocytes derived from experimental autoimmune uveitis-prone B10RIII mice.
Jiang G; Ke Y; Sun D; Han G; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2008 Jan; 49(1):282-9. PubMed ID: 18172104
[TBL] [Abstract][Full Text] [Related]
2. Regulatory role of TLR ligands on the activation of autoreactive T cells by retinal astrocytes.
Jiang G; Ke Y; Sun D; Wang Y; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4769-76. PubMed ID: 19443727
[TBL] [Abstract][Full Text] [Related]
3. HMGB1 release triggered by the interaction of live retinal cells and uveitogenic T cells is Fas/FasL activation-dependent.
Jiang G; Wang Y; Yun J; Hajrasouliha AR; Zhao Y; Sun D; Kaplan HJ; Shao H
J Neuroinflammation; 2015 Sep; 12():179. PubMed ID: 26394985
[TBL] [Abstract][Full Text] [Related]
4. Suppression of established experimental autoimmune uveitis by anti-LFA-1alpha Ab.
Ke Y; Sun D; Zhang P; Jiang G; Kaplan HJ; Shao H
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2667-75. PubMed ID: 17525198
[TBL] [Abstract][Full Text] [Related]
5. Characterization of IL-17+ interphotoreceptor retinoid-binding protein-specific T cells in experimental autoimmune uveitis.
Peng Y; Han G; Shao H; Wang Y; Kaplan HJ; Sun D
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4153-61. PubMed ID: 17724201
[TBL] [Abstract][Full Text] [Related]
6. CTLA4-Ig suppresses development of experimental autoimmune uveitis in the induction and effector phases: Comparison with blockade of interleukin-6.
Iwahashi C; Fujimoto M; Nomura S; Serada S; Nakai K; Ohguro N; Nishida K; Naka T
Exp Eye Res; 2015 Nov; 140():53-64. PubMed ID: 26297802
[TBL] [Abstract][Full Text] [Related]
7. Activated gammadelta T cells promote the activation of uveitogenic T cells and exacerbate EAU development.
Nian H; Shao H; O'Brien RL; Born WK; Kaplan HJ; Sun D
Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5920-7. PubMed ID: 21296823
[TBL] [Abstract][Full Text] [Related]
8. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
[TBL] [Abstract][Full Text] [Related]
9. Abrogation of anti-retinal autoimmunity in IL-10 transgenic mice due to reduced T cell priming and inhibition of disease effector mechanisms.
Agarwal RK; Horai R; Viley AM; Silver PB; Grajewski RS; Su SB; Yazdani AT; Zhu W; Kronenberg M; Murray PJ; Rutschman RL; Chan CC; Caspi RR
J Immunol; 2008 Apr; 180(8):5423-9. PubMed ID: 18390724
[TBL] [Abstract][Full Text] [Related]
10. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
[TBL] [Abstract][Full Text] [Related]
11. Regulation of interphotoreceptor retinoid-binding protein (IRBP)-specific Th1 and Th17 cells in anterior chamber-associated immune deviation (ACAID).
Cui Y; Shao H; Sun D; Kaplan HJ
Invest Ophthalmol Vis Sci; 2009 Dec; 50(12):5811-7. PubMed ID: 19458338
[TBL] [Abstract][Full Text] [Related]
12. S-nitrosoglutathione prevents interphotoreceptor retinoid-binding protein (IRBP(161-180))-induced experimental autoimmune uveitis.
Haq E; Rohrer B; Nath N; Crosson CE; Singh I
J Ocul Pharmacol Ther; 2007 Jun; 23(3):221-31. PubMed ID: 17593005
[TBL] [Abstract][Full Text] [Related]
13. Ex-vivo tolerogenic F4/80⁺ antigen-presenting cells (APC) induce efferent CD8⁺ regulatory T cell-dependent suppression of experimental autoimmune uveitis.
Hsu SM; Mathew R; Taylor AW; Stein-Streilein J
Clin Exp Immunol; 2014 Apr; 176(1):37-48. PubMed ID: 24266626
[TBL] [Abstract][Full Text] [Related]
14. IL-18 not required for IRBP peptide-induced EAU: studies in gene-deficient mice.
Jiang HR; Wei X; Niedbala W; Lumsden L; Liew FY; Forrester JV
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):177-82. PubMed ID: 11133864
[TBL] [Abstract][Full Text] [Related]
15. Repertoire analysis and new pathogenic epitopes of IRBP in C57BL/6 (H-2b) and B10.RIII (H-2r) mice.
Cortes LM; Mattapallil MJ; Silver PB; Donoso LA; Liou GI; Zhu W; Chan CC; Caspi RR
Invest Ophthalmol Vis Sci; 2008 May; 49(5):1946-56. PubMed ID: 18436827
[TBL] [Abstract][Full Text] [Related]
16. Antigen-specific inhibition of experimental autoimmune uveoretinitis by bone marrow-derived immature dendritic cells.
Jiang HR; Muckersie E; Robertson M; Forrester JV
Invest Ophthalmol Vis Sci; 2003 Apr; 44(4):1598-607. PubMed ID: 12657598
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD137 mAb treatment inhibits experimental autoimmune uveitis by limiting expansion and increasing apoptotic death of uveitogenic T cells.
Shao H; Fu Y; Liao T; Peng Y; Chen L; Kaplan HJ; Sun D
Invest Ophthalmol Vis Sci; 2005 Feb; 46(2):596-603. PubMed ID: 15671287
[TBL] [Abstract][Full Text] [Related]
18. IFN-gamma-deficient mice develop experimental autoimmune uveitis in the context of a deviant effector response.
Jones LS; Rizzo LV; Agarwal RK; Tarrant TK; Chan CC; Wiggert B; Caspi RR
J Immunol; 1997 Jun; 158(12):5997-6005. PubMed ID: 9190954
[TBL] [Abstract][Full Text] [Related]
19. Modulating of ocular inflammation with macrophage migration inhibitory factor is associated with notch signalling in experimental autoimmune uveitis.
Yang H; Zheng S; Mao Y; Chen Z; Zheng C; Li H; Sumners C; Li Q; Yang P; Lei B
Clin Exp Immunol; 2016 Feb; 183(2):280-93. PubMed ID: 26400205
[TBL] [Abstract][Full Text] [Related]
20. Identification of a new epitope of human IRBP that induces autoimmune uveoretinitis in mice of the H-2b haplotype.
Avichezer D; Silver PB; Chan CC; Wiggert B; Caspi RR
Invest Ophthalmol Vis Sci; 2000 Jan; 41(1):127-31. PubMed ID: 10634611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
